Protect against market exclusivity in the fight against COVID-19

Nat Med. 2020 Jun;26(6):813. doi: 10.1038/s41591-020-0876-6.
No abstract available

MeSH terms

  • Betacoronavirus / pathogenicity
  • COVID-19
  • COVID-19 Vaccines
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / prevention & control
  • Coronavirus Infections / therapy*
  • Coronavirus Infections / virology
  • Humans
  • Intellectual Property*
  • Pandemics
  • Patents as Topic*
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / therapy*
  • Pneumonia, Viral / virology
  • SARS-CoV-2
  • Viral Vaccines / therapeutic use

Substances

  • COVID-19 Vaccines
  • Viral Vaccines